The NICE year in review

At this time of year we like to stop and reflect on some of the news we’ve shared with you over the past twelve months…


Tuberculosis guidelines help target most vulnerable

Our updated tuberculosis (TB) guidance called for healthcare professionals to raise awareness of how TB spreads amongst people who are most at at-risk (homeless, live in poverty or are drug users).


Ensuring a smooth transition between children's and adult services

We said health and social care professionals should see young people as capable individuals who can make decisions about their own care. And there should be a named care professional to co-ordinate the care of people as they move between services.

Listen to Carrie Wilson talk about her experiences.


Faster access to effective cancer treatments through Cancer Drugs Fund

The NICE board approved new arrangements for the Cancer Drugs Fund (CDF), which will see patients benefitting from new and innovative treatments earlier.


Ataluren is recommended for children with Duchenne muscular dystrophy

NICE’s Highly Specialised Technologies programme committee agreed that ataluren should be made available under a managed access agreement with NHS England. 


We recommend new treatment options for type 2 diabetes recommended by NICE

The three new treatments - canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance) - help to control blood sugar in those patients who cannot take more commonly prescribed medicines. An estimated 31,000 people are eligible.


Thousands of men could benefit from laser treatment for an enlarged prostate

The recommended GreenLight XPS device involves using a laser to vaporise excess prostate tissue. This eases the blocked urethra and leaves a clear channel for urine to flow. The procedure can be done as a day-case meaning the patient can go home that same day.


Sepsis is just as urgent as heart attack

New NICE guidance said quick identification and early treatment are key to avoiding death from sepsis. We called for all health professionals to think about the possibility of sepsis in their patients who have an infection.


New work could prevent thousands of people from suffering a stroke

New NICE indicators will help GPs and CCGs improve the identification and management of atrial fibrillation (AF), a condition that causes an irregular heartbeat and increases the risk of stroke.


Patients should be more involved in decisions about their care

A new collaborative, made up of the UK’s leading healthcare organisations including NICE, sets out plans that will help get patients more involved in decisions about their care.


Patients to get faster access to the most cost-effective treatments

Patients could benefit from the most cost effective treatments nearly three months faster under plans unveiled by NICE and NHS England.


Price cuts pave the way for access to breast cancer drugs

We were about to recommend three life-extending breast cancer drugs - everolimus, eribulin and pertuzumab - after the manufacturers agreed to reduce their prices.


Families with dying children must be put at the heart of care

Our final ‘End of life care for children’ guidance called for everyone working in health and social care to ensure the whole family is supported. Everyone should get the practical and emotional support they need to care for a child at the end of life.

Listen to Dr Emily Harrop talk about our guidance.